ArticleMolecular cancer2025

The landscape of dynamic tumor immunophenotyping on neoadjuvant chemotherapy combined with trastuzumab for the treatment of HER2-positive breast cancer.

Hongtao Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.